Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B C McLeod

Showing results (31-40 of 48) with videos related to

Pageof 5
Sort By:
Transfusion|July 1, 1988
Long-term frequent plasma exchange donation of cryoprecipitateB C McLeod, R J Sassetti, E R Cole, et al.
Lancet (London, England)|September 27, 1980
Factor VIII collection by pheresisB C McLeod, R J Sassetti, E R Cole, et al.
Clinical and Experimental Immunology|April 1, 1975
Binding of the complement intermediate C56 to zymosan in acute phase human seraP J Baker, L G Rubin, T F Lint, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 1, 1975
Studies on the inhibition of C56-induced lysis (reactive lysis). VI. Modulation of C56-induced lysis polyanions and polycationsP J Baker, T F Lint, B C McLeod, et al.
Neurology|August 1, 1982
Plasmapheresis decreases neuroelectric blocking activity in multiple sclerosisD Stefoski, C L Schauf, B C McLeod, et al.
Journal of Clinical Apheresis|January 1, 1991
Plateletpheresis with the COBE spectra single needle access optionB C McLeod, R McKenna, A Viernes, et al.
Transfusion|April 16, 1999
Frequency of immediate adverse effects associated with therapeutic apheresisB C McLeod, I Sniecinski, D Ciavarella, et al.
Transfusion|October 13, 1998
Frequency of immediate adverse effects associated with apheresis donationB C McLeod, T H Price, H Owen, et al.
Journal of Clinical Apheresis|January 1, 1993
An overview of current managementR G Strauss, D Ciavarella, R O Gilcher, et al.
Journal of Clinical Apheresis|January 1, 1993
Management of renal disordersR O Gilcher, R G Strauss, D Ciavarella, et al.
Pageof 5

Showing results (31-40 of 48) with videos related to

Sort By:
Pageof 5
Transfusion|July 1, 1988
Long-term frequent plasma exchange donation of cryoprecipitateB C McLeod, R J Sassetti, E R Cole, et al.
Lancet (London, England)|September 27, 1980
Factor VIII collection by pheresisB C McLeod, R J Sassetti, E R Cole, et al.
Clinical and Experimental Immunology|April 1, 1975
Binding of the complement intermediate C56 to zymosan in acute phase human seraP J Baker, L G Rubin, T F Lint, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 1, 1975
Studies on the inhibition of C56-induced lysis (reactive lysis). VI. Modulation of C56-induced lysis polyanions and polycationsP J Baker, T F Lint, B C McLeod, et al.
Neurology|August 1, 1982
Plasmapheresis decreases neuroelectric blocking activity in multiple sclerosisD Stefoski, C L Schauf, B C McLeod, et al.
Journal of Clinical Apheresis|January 1, 1991
Plateletpheresis with the COBE spectra single needle access optionB C McLeod, R McKenna, A Viernes, et al.
Transfusion|April 16, 1999
Frequency of immediate adverse effects associated with therapeutic apheresisB C McLeod, I Sniecinski, D Ciavarella, et al.
Transfusion|October 13, 1998
Frequency of immediate adverse effects associated with apheresis donationB C McLeod, T H Price, H Owen, et al.
Journal of Clinical Apheresis|January 1, 1993
An overview of current managementR G Strauss, D Ciavarella, R O Gilcher, et al.
Journal of Clinical Apheresis|January 1, 1993
Management of renal disordersR O Gilcher, R G Strauss, D Ciavarella, et al.
Pageof 5